John Eisinger, manager of the top- performing £507m Janus US All Cap Growth fund, has upped his weighting to mid-cap technology companies but is avoiding some of the sector's giants.
Eisinger said recent US stock market volatility has pushed down the share prices of technology companies and made valuations particularly attractive. As a result, he has gradually reallocated 5% of his healthcare weighting into technology, reversing his overweight position in healthcare from last year. "During 2010 healthcare lagged the rest of the market because it was weighed down by concerns over reform. The sector underperformed, presenting some of the best opportunities versus other sectors," said Eisinger. "Technology is different as it has been going up of late because of th...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
